Inventor
Ann Chen
Inventor
Taipei, TW
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes31%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
C07DHeterocyclic compounds3%
C07HSugars3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
G06FElectric digital data processing3%
G06NComputing arrangements based on specific computational models3%
H04LTransmission of digital information, e.g. telegraphic communication3%
PatentTitleYear
11,057,322Ranking messages of conversation graphs in a messaging platform using machine-learning signals202110,357,507Use of ginsenoside M1 for inhibiting renal fibrosis201910,172,876Use of ginsenoside M1 for treating IgA nephropathy20199,844,560Use of ginsenoside M1 for treating lupus nephritis20179,475,789'Use of polyenylpyrrole derivatives for treating inflammation'20169,393,226'Use of osthole for treating focal segmental glomerulosclerosis'20169,321,795'Use of hydroxycinnamaldehyde glycoside derivatives for treating glomerulonephritis'20169,295,705'Treatment for nephritis'20168,993,637'Use of citral for treating focal segmental glomerulosclerosis'20158,785,137'Method for renal disease diagnosis using Rab23 as marker'20148,518,461'Use of bamboo vinegar for treating inflammation'20138,414,938'Schisandrae fructus extracts for inhibition or prevention of H1N1 influenza virus infection and its application thereof'20138,329,410'Method for diagnosing kidney disease comprising detecting the level of annexin A2'20128,329,651'Method for renal disease diagnosis and prognosis using annexin A1 and Rab23 as markers'20128,178,358'Serpine2 as a biomarker for IgA nephropathy'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2016Patents assigned to NAT DEFENSE MEDICAL CT (9)· patent assignee history
2012–2016Patents assigned to CHEN ANN (7)· patent assignee history
2012–2016Patents assigned to KA SHUK-MAN (6)· patent assignee history
2012–2019Based in Taipei, TW· patent location history
2013–2016Patents assigned to CHANG JIA-MING (2)· patent assignee history
2016Based in Xizhi City, TW· patent location history
2019Patents assigned to LEE SHEAU LONG (2)· patent assignee history
2021Based in San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NAT DEFENSE MEDICAL CT | 9 | 2012–2016 |
| CHEN ANNself | 7 | 2012–2016 |
| KA SHUK-MAN | 6 | 2012–2016 |
| CHANG JIA-MING | 2 | 2013–2016 |
| LEE SHEAU LONG | 2 | 2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Taipei, TW | 13 | 2012–2019 |
| San Francisco, California, US | 1 | 2021 |
| Xizhi City, TW | 1 | 2016 |